CARDINAL HEALTH INC (CAH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 25B 50B 75B Q3 '21: 39.3B Q4 '21: 42.6B Q1 '22: 44B Q2 '22: 45.5B Q3 '22: 44.8B Q4 '22: 47.1B Q1 '23: 49.6B Q2 '23: 51.5B Q3 '23: 50.5B Q4 '23: 53.4B Q1 '24: 54.6B Q2 '24: 57.4B Q3 '24: 54.9B Q4 '24: 59.9B Q1 '25: 52.3B Q2 '25: 55.3B Q3 '25: 54.9B Q4 '25: 60.2B Q1 '26: 64B Q2 '26: 65.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 900M 1.8B 2.7B Q3 '21: 1.8B Q4 '21: 1.5B Q1 '22: 1.6B Q2 '22: 1.6B Q3 '22: 1.7B Q4 '22: 1.5B Q1 '23: 1.6B Q2 '23: 1.7B Q3 '23: 1.8B Q4 '23: 1.8B Q1 '24: 1.7B Q2 '24: 1.9B Q3 '24: 1.9B Q4 '24: 1.9B Q1 '25: 1.9B Q2 '25: 1.9B Q3 '25: 2.1B Q4 '25: 2.2B Q1 '26: 2.3B Q2 '26: 2.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-1.1B -700M -350M 0 350M 700M 1.1B Q3 '21: 473M Q4 '21: 162M Q1 '22: 415M Q2 '22: -950M Q3 '22: -97M Q4 '22: 25M Q1 '23: 137M Q2 '23: -119M Q3 '23: 572M Q4 '23: 162M Q1 '24: -32M Q2 '24: 505M Q3 '24: 369M Q4 '24: 401M Q1 '25: 568M Q2 '25: 549M Q3 '25: 730M Q4 '25: 428M Q1 '26: 668M Q2 '26: 707M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '21: 119M Q4 '21: 116M Q1 '22: 271M Q2 '22: 49M Q3 '22: -1.4B Q4 '22: 133M Q1 '23: 110M Q2 '23: -130M Q3 '23: 345M Q4 '23: 5M Q1 '24: -12M Q2 '24: 368M Q3 '24: 261M Q4 '24: 235M Q1 '25: 416M Q2 '25: 400M Q3 '25: 506M Q4 '25: 239M Q1 '26: 450M Q2 '26: 467M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 25B 50B 75B Q3 '21: 37.5B Q4 '21: 41.1B Q1 '22: 42.3B Q2 '22: 43.8B Q3 '22: 43.2B Q4 '22: 45.5B Q1 '23: 48B Q2 '23: 49.8B Q3 '23: 48.7B Q4 '23: 51.6B Q1 '24: 52.9B Q2 '24: 55.6B Q3 '24: 52.9B Q4 '24: 58B Q1 '25: 50.4B Q2 '25: 53.3B Q3 '25: 52.8B Q4 '25: 58B Q1 '26: 61.7B Q2 '26: 63.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-3B -1.5B 0 1.5B 3B 4.5B Q3 '21: 277M Q4 '21: 665M Q1 '22: -646M Q2 '22: 1.2B Q3 '22: -419M Q4 '22: 3B Q1 '23: 23M Q2 '23: 597M Q3 '23: 1.4B Q4 '23: 863M Q1 '24: 528M Q2 '24: 1.2B Q3 '24: -27M Q4 '24: 2.1B Q1 '25: -1.6B Q2 '25: -396M Q3 '25: 2.9B Q4 '25: 1.5B Q1 '26: 973M Q2 '26: 686M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-2B -1B 0 1B 2B 3B Q3 '21: 177M Q4 '21: 539M Q1 '22: -713M Q2 '22: 1.1B Q3 '22: -501M Q4 '22: 2.9B Q1 '23: -47M Q2 '23: 512M Q3 '23: 1.3B Q4 '23: 646M Q1 '24: 436M Q2 '24: 1.1B Q3 '24: -139M Q4 '24: 1.9B Q1 '25: -1.7B Q2 '25: -495M Q3 '25: 2.8B Q4 '25: 1.3B Q1 '26: 865M Q2 '26: 555M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 296M Q2 '20: 294M Q3 '20: 294M Q1 '21: 293M Q2 '21: 295M Q3 '21: 294M Q1 '22: 289M Q2 '22: 281M Q3 '22: 275M Q1 '23: 273M Q2 '23: 261M Q3 '23: 258M Q1 '24: 249M Q2 '24: 246M Q3 '24: 245M Q1 '25: 245M Q2 '25: 243M Q3 '25: 241M Q1 '26: 239M Q2 '26: 237M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q3 '12: 2.96 Q4 '12: 3.06 Q1 '13: 3.17 Q2 '13: 3.30 Q3 '13: 3.35 Q4 '14: 3.38 Q1 '15: 3.17 Q2 '15: 3.23 Q3 '15: 3.41 Q4 '15: 3.61 Q1 '16: 3.98 Q2 '16: 4.10 Q3 '16: 4.18 Q4 '16: 4.32 Q4 '23: 1.26 Q1 '24: 0.81 Q2 '24: 2.61 Q3 '24: 2.27 Q4 '24: 3.45 Q1 '25: 5.20 Q4 '12 Q3 '13 Q2 '15 Q1 '16 Q4 '16 Q2 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.